Life Science Instrumentation Market Worth 75.24 Billion USD by 2022

Friday, September 22, 2017 Lifestyle News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, September 22, 2017 /PRNewswire/ --

According to a new market research report "Life Science Instrumentation Market

by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022",
published by MarketsandMarkets™, the market is projected to reach USD 75.24 Billion by 2022 from USD 54.49 Billion in 2017, at a CAGR of 6.7%.

     (Logo: )

Browse 106 Market Data Tables and 76 Figures spread through 334 Pages and in-depth TOC on "Life Science Instrumentation Market" Early buyers will receive 10% customization on this report

Factors such as the increased spending on pharmaceutical R&D globally, rising food safety concerns, technological advancements in analytical instruments, and funding available for life science research activities are driving the growth of this market.

The next-generation sequencing (NGS) is expected to be the fastest growing technology segment during the forecast period 

By technology, the NGS segment is expected to grow at the fastest CAGR during the forecast period (2017-2022). The growth of this segment can primarily be attributed to the increasing focus of key players on technological advancements in sequencing platforms and the growing applications of NGS.

Download PDF Brochure:

By application, the research segment is expected to be the fastest growing segment 

The research applications segment is expected to grow at the fastest CAGR during the forecast period. The growth of this segment can be attributed to the evolving global regulatory scenario for research data publication for analytical instrument-based researches; increasing number of research studies and growing public-private funding in the field of genomic research; and the ongoing trend of laboratory automation & integration of robotics.

North America dominated the market in 2016 

Geographically, the Life Science Instrumentation Market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). North America accounted for the largest share of the market in 2017, followed by Europe.

Talk To Our Research Analysts:

High adoption rate of novel technologies, the large number of life science research studies conducted in the region, stringent drug development regulations, increased funding for life science research activities, and the growing numbers of metabolomics research studies in North America are the key factors that account for the large share of the Life Science Instrumentation Market in the region.

As of 2016, the major manufacturers operating in the global Life Science Instrumentation Market included Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc. (US), and Waters Corporation (US), Shimadzu Corporation (Japan), Illumina, Inc. (US), Siemens AG (Germany), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), and Hitachi High-Technologies Corporation (Japan), among others.

Browse Related Reports 

DIGITAL PCR AND REAL-TIME PCR (qPCR) MARKET by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, CRO) - Forecast to 2022

CHROMATOGRAPHY INSTRUMENTS MARKET by Type (Systems, Detectors), Consumables (Columns) and Accessories (Auto-sampler Accessories), Applications (Life science Research, Environmental Testing, Food & Beverage Testing), and Region - Global Forecast to 2022  

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: +1-888-600-6441 Email:

Visit Our Blog@

Connect with us on LinkedIn @

SOURCE MarketsandMarkets

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store